References
- Aye M, Di Giorgio C, Mekaouchec M, Steinberga J-G, Brerro-Sabya C, Barthélémyd P, De Méob M, Jammesa Y. Genotoxicity of intraperitoneal injection of lipoamphiphile CdSe/ZnSquantum dots in rats. Mutat Res, 2013;758:48–55
- Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science, 1998;281:2016–18
- Chang TM. Future generations of red blood cell substitutes. J Intern Med, 2003;253:527–35
- Chen BJ, Wiley B, Li Z-Y, Campbell D, Saeki F, Cang H, Au L, Lee J, Li X, Xia Y. Gold nanocages: Engineering their structure for biomedical applications. Adv Mater, 2005;17:2255–61
- Council EPAE. 2010. European Commission (2010). Directive 2010/63/EU on protecion of animals used for scientific purposes. Ispra, Italy: Institute for Health and Consumer Protection
- Derfus AM, Chan WC, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Letters, 2004;4:11–18
- Finder C, Wohlgemuth M, Mayer C. Analysis of particle size distribution by particle tracking. Part Part Syst Charact, 2004;21:372–8
- Galangau O, Dumas-Verdes C, Meallet-Renault R, Clavier G. Rational design of visible and NIR distyryl-BODIPY dyes from a novel fluorinated platform. Org Biomol Chem, 2010;8:4546–53
- Geddes CD. Luminescent blinking of gold nanoparticles. Chem Phys Lett, 2003;380:269–72
- Geyer RP. Whole animals perfusion with fluorocarbon dispersions. Fed Proc, 1970;29:1758–63
- Graf A, Ablinger E, Peters S, Zimmer A, Hook S, Rades T. Microemulsions containing lecithin and sugar-based surfactants: Nanoparticle templates for delivery of proteins and peptides. Int J Pharm, 2008;350:351–60
- Graf A, Rades T, Hook SM. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: Optimisation and in vivo evaluation. Eur J Pharm Sci, 2009;37:53–61
- Harris DH, Lappert F. Monomeric, volatile bivalent amides of group IVB elements, M(NR12)2 and M(NR1R2)2 (M=Ge, Sn, or Pb; R1=Me3Si, R2=Me3C). JCS Chem Comm, 1974;21:895–96
- Henkel-Honke T, Oleck M. Artificial oxygen carriers: A current review. AANA J, 2007;75:205–11
- Iizawa O, Kato T, Tagami H, Akamatsu H, Niwa Y. Long-term follow-up study of changes in lipid peroxide levels and the activity of superoxide dismutase, catalase and glutathione peroxidase in mouse skin after acute and chronic UV irradiation. Arch Dermatol Res, 1994;286:47–52
- Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J Phys Chem B, 2006;110:7238–48
- Kligman LH, Akin FJ, Kligman AM. The contributions of UVA and UVB to connective tissue damage in hairless mice. J Invest Dermatol, 1985;84:272–6
- Kligman LH, Duo CH, Kligman AM. Topical retinoic acid enhances the repair of ultraviolet damaged dermal connective tissue. Connect Tissue Res, 1984;12:139–50
- Kriebig U, Vollmer M. 1995. Optical properties of metal clusters. New York: Springer
- Leland CCJ, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science, 1966;152:1755–6
- Liu X. Surfactant-free synthesis and functionalization of highly fluorescent gold quantum dots. J Phys Chem, 2008;112:10778–83
- Lowe KC. Engineering blood: Synthetic substitutes from fluorinated compounds. Tissue Eng, 2003;9:389–99
- Pietkiewicz J, Zielinska K, Saczko J, Kulbacka J, Majkowski M, Wilk KA. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: Hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur J Pharm Sci, 2010;39:322–35
- Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 2006;22:4397–402
- Riess JG. Oxygen carriers (“blood substitutes”) – Raison d'etre, chemistry, and some physiology. Chem Rev, 2001;101:2797–920
- Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion, 1990;30:583–90
- Stanworth SJ, Cockburn HA, Boralessa H, Contreras M. Which groups of patients are transfused? A study of red cell usage in London and southeast England. Vox Sang, 2002;83:352–7
- Stephan C, Schlawne C, Grass S, Waack IN, Ferenz KB, Bachmann M, Barnert S, Schubert R, Bastmeyer M, De Groot H, Mayer C. Artificial oxygen carriers based on perfluorodecalin-filled poly(n-butyl-cyanoacrylate) nanocapsules. J Microencapsul, 2014;31(3):284–92
- Tappenden J. Artificial blood substitutes. J R Army Med Corps, 2007;153:3–9
- Ulrich G, Ziessel R, Harriman A. The chemistry of fluorescent bodipy dyes: Versatility unsurpassed. Angew Chem Int Ed Engl, 2008;47:1184–201
- Veeckman L. Artificial blood substitutes. Curr Opin Anaesthesiol, 1997;10:280–3
- Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, Mcclelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. BMJ, 1999;319:16–19
- Winslow RM. Current status of oxygen carriers (‘blood substitutes'): 2006. Vox Sang, 2006;91:102–10